Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by narmacon Nov 08, 2021 7:15pm
112 Views
Post# 34102602

RE:RE:RE:RE:RE:RE:RE:RE:Aposense updating website

RE:RE:RE:RE:RE:RE:RE:RE:Aposense updating website"Show me where you posted that 8 years ago."

Not off hand,,but yes,,you would find a number of my posts noting this very opinion in reference to BTI and also RVX,,,,,they have how many other special molecules out side of 208 sitting on the sideline for years!!! and years !!! Is one to assume no partner is interested in bringing hope to people with some of these disabilitating diseases. Or,,,,is the RVX management team so full of greed they will not offer even one molecule into the lap of humanity. Either way shareholders are also left on these same sidelines. I could see it if a research company is a one horse show,,,,,,,,just another bored board opinion.
<< Previous
Bullboard Posts
Next >>